StockData
Kairos Pharma, LTD. logo

Kairos Pharma, LTD. (KAPA) stock

KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.44+0.04 (+10.08%)

Close on Nov 18, 2026Market cap $1.64MP/E –Yield –

Kairos Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Kairos Pharma

Kairos Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Kairos Pharma figures

See a number that looks wrong?